
Could Sangamo Therapeutics Inc (SGMO) Stock Be Headed for a Major Gains?
Truist has recently raised Sangamo Therapeutics Inc (SGMO) stock to Buy rating, as announced on December 13, 2024, according to Finviz. Earlier, on December 10,
Truist has recently raised Sangamo Therapeutics Inc (SGMO) stock to Buy rating, as announced on December 13, 2024, according to Finviz. Earlier, on December 10,
MetaVia Inc (MTVA) Stock Trading Recap On Wednesday, MetaVia Inc (MTVA) stock saw a modest uptick, ending the day at $0.70 which represents a slight
Barclays has recently raised NetApp Inc (NTAP) stock to Overweight rating, as announced on April 30, 2025, according to Finviz. Earlier, on February 28, 2025,
UBS has recently initiated McCormick & Company Inc (MKC) stock to Neutral rating, as announced on June 16, 2025, according to Finviz. Earlier, on March
KeyBanc Capital Markets has recently initiated Akamai Technologies Inc (AKAM) stock to Underweight rating, as announced on June 6, 2025, according to Finviz. Earlier, on
JP Morgan has recently raised Cognizant Technology Solutions Corp (CTSH) stock to Overweight rating, as announced on May 19, 2025, according to Finviz. Earlier, on
Raymond James has recently reduced CBRE Group Inc (CBRE) stock to Outperform rating, as announced on January 24, 2025, according to Finviz. Earlier, on January
Jefferies has recently reduced Middleby Corp (MIDD) stock to Hold rating, as announced on December 12, 2024, according to Finviz. Earlier, on June 28, 2024,
Redburn Atlantic has recently reduced Manhattan Associates Inc (MANH) stock to Neutral rating, as announced on June 10, 2025, according to Finviz. Earlier, on April
Citigroup has recently reduced Lamb Weston Holdings Inc (LW) stock to Neutral rating, as announced on December 20, 2024, according to Finviz. Earlier, on December
BOVNews.com was originated in 2018 as a Company. Our team comprises Analysts and writers with the knowledge and expertise of Stock Markets and other sectors of Finance.
Copyright©2024, BOVNews.com